
Evidence of deliberate climate damage
For decades, some members of the fossil fuel industry tried to convince the public that a causative link between fossil fuel use and climate warming...

Amgen wins race of top `22 deals with $26bn for Horizon thx
Horizon confirmed Amgen's interest in a press release. The American group is to offer around $116.5 for each share. The offer price is about 20...

Resolve Biosciences secures US$71m in funding
The current Series B financing brings Mohnheim-based Resolve Biosciences’ financing up to a total of more than $100m. The finance round followed the...

CatalYm GmbH raises €50m to push visugromab development
Following a €60m Series B financing in 2020, Martinsried-based CatalYm GmbH announced the closing of a Series C financing round of €50m. The...

C4X Discovery Holdings inks $402m deal with AstraZeneca
Under the agrrement, C4X Discovery Holdings plc (C4XD) will receive pre-clinical milestone payments worth up to $16m ahead of the first clinical...

Standing Ovation inks exlusive partnership with Bel Group
Just one month after Standing Ovation SA won the start-up pitch at INDUSTRIA BIOTEC and got a €16m Series A financing, the two-year old company has...

Bone Therapeutics merges with Medsenic and changes name
The combination of Medsenic and Bone Therapeutics will expand Bone Therapeutics' allogeneic cell therapy-based product portfolio in orthopedics...